Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs

    October 2019 in “ Cancers
    Tomomi Sanomachi, Shuhei Suzuki, Keita Togashi, Asuka Sugai, Shizuka Seino, Masashi Okada, Takashi Yoshioka, Chifumi Kitanaka, Masahiro Yamamoto
    Image of study
    TLDR Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.
    The study from October 14, 2019, demonstrated that spironolactone, a diuretic drug, has the potential to enhance the effectiveness of non-DNA-damaging anticancer drugs like gemcitabine and osimertinib by increasing cell death and inhibiting cell growth in various cancer cells, including lung, pancreatic, and glioblastoma, as well as cancer stem cells, without being toxic to normal cells. It was found that spironolactone reduces the expression of survivin, an anti-apoptotic protein, and that both pharmacological and genetic suppression of survivin further sensitized cancer cells to these anticancer drugs. In vivo experiments with a mouse xenograft model showed that combining spironolactone with the anticancer drugs significantly suppressed tumor growth without apparent adverse effects. The study concluded that spironolactone could be a safe and effective drug for enhancing the effects of certain anticancer drugs through the suppression of survivin. The number of participants or cells used in the study was not mentioned in the summary.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 348 results

      community Hair loss treatments rated (by gpt-4)

      in Research/Science  253 upvotes 1 year ago
      Rating treatments for hair loss, with the help of GPT-4, according to efficacy, evidence and tolerability; a combination of chemicals from research papers, custom compounds, and some suggestions from other users were included.

      community Spironolactone VS dutasteride for female pattern hair loss

      in Treatment  7 upvotes 3 months ago
      Spironolactone is more potent and lowers testosterone and DHT, while dutasteride only impacts DHT. For female hair loss, checking hormones and considering treatments like oral minoxidil, spironolactone, or topical minoxidil is recommended.

      community Spironolactone, what do you think?

      in Finasteride/Dutasteride  4 upvotes 4 months ago
      A user is considering Spironolactone for hair loss but is advised against it due to its effects on testosterone. Instead, they are recommended to try finasteride at 18 and consider dutasteride if needed.

      community Spironolactone for 11 years, finasteride for almost 5 years, started oral minoxidil in November 😢 ended oral contraceptive in Dec.

      in Progress Pictures  224 upvotes 8 months ago
      A user shared their 11-year experience with spironolactone and nearly 5 years with finasteride for hair loss, recently adding oral minoxidil and stopping birth control. Various treatments were discussed, including organic options, checking for underlying health issues, considering dutasteride, and the potential role of progesterone in hair loss.

      community Spironolactone topically with a try ?!

      in Research/Science  1 upvotes 9 months ago
      A 30-year-old male is considering using dutasteride and fluridil for hair loss maintenance and is curious about the effectiveness of topical spironolactone, as he cannot take finasteride. He is also planning a hair transplant.

      community Spironolactone or bicalutamide prescription

      in Treatment  4 upvotes 1 year ago
      The conversation is about someone seeking a doctor in the EU who prescribes spironolactone or bicalutamide for female pattern hair loss, as they are having difficulty finding treatment options beyond Minoxidil in Austria. They are asking for recommendations and are open to direct messages for assistance.

    Related Research

    1 / 1 results